Transport of cell adhesion molecules: How does Rab21 organise integrin trafficking on a mechanistic level?
Transport of cell adhesion molecules: How does Rab21 organise integrin trafficking on a mechanistic level?
批准号:
242476905
负责人:
Professor Dr. Martin Aepfelbacher, since 2/2017
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2013
资助国家:
德国
项目状态:
已结题
起止时间:
2012-12-31 至 2016-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Numerous diseases such as cancer progression, inflammation and degenerative disorders are results of deregulated cell adhesion and migration. The integrin family of transmembrane cell surface receptors have a decisive impact on the migratory and invasive capacities of cancer and immune cells. Furthermore, a variety of pathogens use integrins to invade host cells for infection, extending the relevance of integrins to infectious diseases. It is becoming increasingly evident that not only activation/deactivation, but also the endo-/exocytic cycle of integrins plays an important role in mediating integrin function. The small Ras-family GTP-binding protein Rab21, which binds to the cytoplasmic tail of alpha-integrins, is a major regulator in the endocytic trafficking of integrins. However, on a molecular or structural level the mode of action remains poorly understood mainly due to the lack of known Rab21-interacting proteins.The aim of the proposed research is to gain insights how Rab21 organises integrin trafficking on a structural-mechanistic level. To answer this question, three projects will be implemented.A) Identification of Rab21 effector proteins involved in integrin trafficking.Novel Rab21 downstream effector proteins will be identified using a quantitative mass spectrometry-based protein-protein interaction screen and tested regarding their influence on integrin trafficking.B) Structural analysis of the Rab21-integrin trafficking network. After their identification, Rab21 downstream effectors as well as the cytoplasmic tail of alpha-integrins will be crystallised in complexes with Rab21 to obtain a structural snapshot of the Rab21-regulated integrin trafficking network. The X-ray structures will provide insights into the function of the trafficking complex and answer the question how Rab21 manages to transport cargo (integrin) and bind effector proteins in parallel.C) Functional analysis of the Rab21 effector proteins. I will investigate the biochemical and cell biological function of the identified effector proteins and address the question how these effector proteins effect the dynamics of integrin endocytosis. Different microscopy techniques (confocal microscopy, live cell imaging, TIRF) will be employed.In this proposed research, I will employ a multidisciplinary approach starting with a biochemical screen and combining various state of the art and cutting edge cell and structural biological tools to maximise our mechanistic understanding of the question how integrins are trafficking from the plasma membrane to endosomes and how this trafficking influences different disease processes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
全细胞疫苗Cell@MnO2的乳腺癌术后免疫响应监测与放射免疫治疗研究
-
批准号:QN25H220002
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:顾媛
-
依托单位:
染色体外环状DNA以cell-in-cell途径促进基因横向传递和扩增的研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:王锐智
-
依托单位:
GMFG/F-actin/cell adhesion 轴驱动 EHT 在造
血干细胞生成中的作用及机制研究
-
批准号:TGY24H080011
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:李鸿鹄
-
依托单位:
糖尿病ED中成纤维细胞衰老调控内皮细胞线粒体稳态失衡的机制研究
-
批准号:82371634
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:赵福军
-
依托单位:
基于In-cell NMR策略对“舟楫之剂”桔梗中引经药效物质的快速发现研究
-
批准号:82305053
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:王丽明
-
依托单位:
配子生成素GGN不同位点突变损伤分子伴侣BIP及HSP90B1功能导致精子形成障碍的发病机理
-
批准号:82371616
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:姚晨成
-
依托单位:
骨髓ISG+NAMPT+中性粒细胞介导抗磷脂综合征B细胞异常活化的机制研究
-
批准号:82371799
-
项目类别:面上项目
-
资助金额:47.00万元
-
批准年份:2023
-
负责人:杨程德
-
依托单位:
利用CRISPR内源性激活Atoh1转录促进前庭毛细胞再生和功能重建
-
批准号:82371145
-
项目类别:面上项目
-
资助金额:46.00万元
-
批准年份:2023
-
负责人:陶永
-
依托单位:
IL-4协同精氨酸优化种植初期巨噬细胞胞葬作用和成骨微环境的作用及机制研究
-
批准号:82370923
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:张文杰
-
依托单位:
胆固醇合成蛋白CYP51介导线粒体通透性转换诱发Th17/Treg细胞稳态失衡在舍格伦综合征中的作用机制研究
-
批准号:82370976
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:郑凌艳
-
依托单位: